Plain-English translation of NCT05486000 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a device called an atrial shunt implant system — a small device placed in the heart to help reduce pressure and relieve symptoms in people with chronic left heart failure. Researchers will implant this device in 120 patients and follow them closely over time to see if it is safe and effective at improving how patients feel and function.
Many people with heart failure continue to have bothersome symptoms even when taking the best available medications. This trial exists to see whether this new implanted device can help by reducing pressure in the heart and giving patients relief they cannot get from medications alone.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo a surgical procedure to have the atrial shunt implant device placed in your heart. You will then return for follow-up visits at 30 days after surgery, 3 months, 6 months, and 12 months — and possibly longer — so researchers can check how well the device is working and monitor you for any side effects. During these visits, you may have heart tests, blood work, and imaging studies to evaluate your progress.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China